Manufacturers trying to implement these solutions have to supply robust validation information to display their equivalence to pharmacopoeial approaches. As these new technologies arise, the WHO emphasizes the importance of an intensive threat evaluation and validation procedure. From the design with the isolator itself into the protocols for testing https://tailinscitech.wixsite.com/tailinscitech/post/hydrophilic-pvdf-membrane-key-applications-and-advantages